Who Paid My Doc
AMG 160_Combo in Prostate Cancer_20180101
Research payments
$11,173,619
Through program year 2024, $11,173,619 in research payments was reported against AMG 160_Combo in Prostate Cancer_20180101, across 202 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $92,858 | 9 |
| 2023 | Research | $297,111 | 7 |
| 2022 | Research | $1,445,913 | 40 |
| 2021 | Research | $5,354,360 | 58 |
| 2020 | Research | $3,626,364 | 61 |
| 2019 | Research | $357,013 | 27 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Karen Autio New York, NY Named on 20 payments
- Tanya Dorff Duarte, CA Named on 19 payments
- Matthew Rettig Los Angeles, CA Named on 18 payments
- Russell Pachynski Saint Louis, MO Named on 10 payments
- Roberto Pili Indianapolis, IN Named on 8 payments
- Mehmet Bilen Atlanta, GA Named on 7 payments
- Scott Tagawa New York, NY Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.